Silver Bullet Therapeutics, Inc. news

Silver Bullet Therapeutics, Inc., a privately held medical device company that has developed an antimicrobial technology for implantable medical devices such as orthopedic bone screws, reported today the results of a study testing th

Silver Bullet Therapeutics, Inc., a privately-held medical device company committed to the development of antimicrobial medical devices, announced today that the U.S. Patent and Trademark Office allowed a new patent, BONE IMPLANTS FOR THE TREATMENT OF INFECTION. The company also announced that it has made an expedited CE Mark filing for a significantly expanded OrthoFuzIon Antimicrobial Bone Screw System product line.

“Not only has our IP portfolio swelled to 14 US

Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the U.S. Patent and Trademark Office allowed two new patents that include, COATINGS FOR THE CONTROLLABLE RELEASE OF ANTIMICROBIAL METAL IONS and BONE IMPLANT AND SYSTEMS THAT CONTROLLABLY RELEASES SILVER. The Company also announced that they will make the OrthoFuzIon Antimicrobial Bone Screw System commercially available to select institutions beginning this Fall in Europe.

The

Silver Bullet Therapeutics, Inc., a privately-held medical device company, announced today that the U.S. Patent and Trademark Office issued Patent No. 8,999,367 as a continuation of patent No. 8,927,004 that significantly enhances the claims for the release of antimicrobial metal ions to prevent infection.

Paul Chirico, President and CEO of Silver Bullet Therapeutics stated, “We take a lot of pride in not only our medical solutions, but also the breadth of our growi